Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Τρίτη 9 Μαΐου 2017

Multimorbidity in Bullous Pemphigoid: a case-control analysis of BP patients with age and gender matched controls

Abstract

Background

Bullous Pemphigoid (BP) is the most common autoimmune blistering disease in the elderly and is associated with increased mortality. The extent of multimorbidity in patients with BP and its impact on survival is unclear.

Objectives

To describe the extent and spectrum of multimorbidity in patients with BP and to ascertain its impact on survival.

Methodology

This was a case-control study conducted in the setting of an academic medical centre. Cases defined as newly diagnosed BP patients referred to the inpatient dermatology service between 2005 and 2014. For every case, 3 age- and gender-matched controls were randomly selected. Retrospective review of medical records was performed. Univariate and multivariate comparisons of cases and controls were performed using conditional logistic regression.

Results

105 cases and 315 controls were included in this study. 88 cases (84%) were multi-morbid (≥ 2 chronic diseases) as compared to 205 controls (65%) (p < 0.001), while the mean no. of comorbid conditions was 3.2 +/- 1.6 in cases compared to 2.4 +/- 1.6 in controls (p < 0.001). 43% of cases had ≥ 4 comorbidities compared to 27% in controls (p = 0.003). On multivariate analysis (adjusting for age, gender and comorbidities), neurological disease OR 10.93 (CI: 5.74, 20.79), hypertension OR 2.38 (1.18, 4.77) were positively associated with BP. Charlson comorbidity index was 6.0 +/- 2.5 in cases compared to 5.0 +/- 2.1 in controls (p = 0.002), and the 1-year mortality of cases and controls were 21.0% and 17.8% respectively.

Conclusion

Our study has shown that a significant proportion of patients with BP are multi-morbid, and individually has a higher no. of comorbidities compared to matched controls. Disease burden and multimorbidity may well impact the prognosis of patients with BP.

This article is protected by copyright. All rights reserved.



http://ift.tt/2qmU89E

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου